DVL1 and breast carcinoma: Very intriguingly, while the K69 and K285 residues not only regulate DVL-1 nuclear translocation, they also regulate gene expression by modulating DVL-1 binding to Wnt target gene promoters in different breast cancer models, yet again indicating a more expansive role of DVL beyond the cytoplasm [24–26].